These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32163529)

  • 41. Predictors of the usefulness of mirogabalin for neuropathic pain: a single-institution retrospective study.
    Kanbayashi Y; Amaya F; Ikoma K; Ueno H; Tabuchi Y; Ishikawa T; Takayama K; Taguchi T
    Pharmazie; 2020 Nov; 75(11):602-605. PubMed ID: 33239138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment.
    Kato M; Tajima N; Shimizu T; Sugihara M; Furihata K; Harada K; Ishizuka H
    J Clin Pharmacol; 2018 Jan; 58(1):57-63. PubMed ID: 28834546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somnolence and Dizziness During Mirogabalin Treatment in Patients With Neuropathic Pain Related to Lumbar Disease Who Switched From Pregabalin: A Retrospective Study.
    Akazawa T; Inoue G; Tanaka M; Umehara T; Nagai T; Oshita Y; Imura T; Miyagi M; Saito W; Sako K; Nomura S; Hiyama A; Katoh H; Sakai D; Sato M; Yoshida A; Iinuma M; Niki H; Takaso M; Watanabe M
    Global Spine J; 2023 Jun; 13(5):1319-1324. PubMed ID: 34325544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between the dose titration and adherence of mirogabalin in patients with peripheral neuropathic pain depending on renal function: a nationwide electronic medical record database study.
    Kato K; Kodama S; Shiosakai K; Kimura T
    Expert Opin Pharmacother; 2023 Feb; 24(2):267-282. PubMed ID: 36503333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
    Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
    Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.
    Freynhagen R; Serpell M; Emir B; Whalen E; Parsons B; Clair A; Latymer M
    Pain Pract; 2015 Jan; 15(1):47-57. PubMed ID: 24279736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha
    Calandre EP; Rico-Villademoros F; Slim M
    Expert Rev Neurother; 2016 Nov; 16(11):1263-1277. PubMed ID: 27345098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mirogabalin, a novel ligand for α
    Murasawa H; Pawlak A; Kobayashi H; Saeki K; Yasuda SI; Kitano Y
    Biomed Pharmacother; 2021 Jul; 139():111647. PubMed ID: 33940507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naturally Inspired Molecules for Neuropathic Pain Inhibition-Effect of Mirogabalin and Cebranopadol on Mechanical and Thermal Nociceptive Threshold in Mice.
    Sałat K; Zaręba P; Awtoniuk M; Sałat R
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A large-scale database study for the prescription status of a new voltage-gated Ca
    Ushida T; Yokoyama M; Shiosakai K; Saito K; Ibe S; Okuizumi K
    Expert Opin Pharmacother; 2022 Feb; 23(2):273-283. PubMed ID: 34928189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan.
    Gray E; Ye X; Wang YF; Wang SJ
    Value Health Reg Issues; 2021 May; 24():148-156. PubMed ID: 33582418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of Mirogabalin in Central Neuropathic Pain After Stroke: Post Hoc Analysis of a Phase 3 Study by Stroke Type and Location.
    Hosomi K; Katayama Y; Sakoda H; Kikumori K; Kuroha M; Ushida T
    Pain Ther; 2024 Oct; 13(5):1151-1171. PubMed ID: 38963656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of coadministration of metformin with mirogabalin: Results from a phase 1, randomized, open-label, drug-drug interaction study
.
    Dow J; Currie A; He L; Zaidi F; Zahir H
    Int J Clin Pharmacol Ther; 2018 Oct; 56(10):451-458. PubMed ID: 30049303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain.
    Schug SA; Parsons B; Almas M; Whalen E
    Pain Physician; 2017; 20(1):E53-E63. PubMed ID: 28072797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pregabalin for the treatment of painful neuropathy.
    Sonnett TE; Setter SM; Campbell RK
    Expert Rev Neurother; 2006 Nov; 6(11):1629-35. PubMed ID: 17144773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
    Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
    Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of Voltage-gated Calcium Channel α2δ Subunit Ligands for the Treatment of Chronic Neuropathic Pain and Insight into Structure-activity Relationship (SAR) by Pharmacophore Modeling.
    Chen Y; Wu Q; Jin Z; Qin Y; Meng F; Zhao G
    Curr Med Chem; 2022 Aug; 29(30):5097-5112. PubMed ID: 35392779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.